CollPlant Biotechnologies GAAP EPS of -$0.87, revenue of $11.43M; reaffirms FY 2026 outlook
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.